Skip to content

Leadership

Spearheaded by Chairman of the Board and Chief Executive Officer (CEO) David Pyott, recognized as one of America's best-rated CEOs,1,2 and backed by a strong and experienced senior management team,3,4 Allergan possesses a unique blend of talent, skills, science and business acumen to anticipate and respond to its customer and patient needs.

Together, Allergan's executive team sets a precedent for commitment that extends throughout the company: commitment to understanding and meeting the unmet medical needs of patients; to fiscal, social and corporate responsibility; and to listening to our customers and employees. As a result, we share a unified vision of what it means to bring the best of medicine to life. We actualize this vision through the execution of our strategic objectives as a company, and consider it realized when innovative ideas are translated into products that make life better.

Executive Committee

David E.I. PyottF. Michael BallRaymond H. DiradoorianJeffrey L. EdwardsDouglas S. Ingram, J.D.Scott M. Whitcup

David E.I. Pyott  

Chairman of the Board and Chief Executive Officer

Jeffrey L. Edwards  

Executive Vice President, Finance and Business Development, Chief Financial Officer

F. Michael Ball  

President

Douglas S. Ingram, J.D. 

Executive Vice President, Chief Administrative Officer, General Counsel and Secretary, and Chief Ethics Officer

Raymond H. Diradoorian  

Executive Vice President, Global Technical Operations

Scott M. Whitcup, M.D.  

Executive Vice President, Research and Development


Board of Directors

Board of Directors

From left to right:



  1. Institutional Investor, Survey of the Best CEOs in America, Allergan's David Pyott was rated #1 in the Specialty Pharma category. January 2005

  2. Institutional Investor, Survey of the BEST CEOs in America, Allergan's David Pyott was again named on the top CEOs in America. January 2007

  3. Forbes. America's Best Managed Companies, Allergan ranked #6 among drug companies. January 2006

  4. Institutional Investor. America's Most Shareholder-Friendly Companies, Allergan ranked #1 in the Specialty Pharma category. February 2006